These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Gabriel SE; Perry HO; Oleson GB; Bowles CA Medicine (Baltimore); 1988 Jan; 67(1):58-65. PubMed ID: 3336281 [TBL] [Abstract][Full Text] [Related]
13. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Kulczycki A; Nelson M; Eisen A; Heffernan M Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909 [TBL] [Abstract][Full Text] [Related]
14. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms. Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560 [TBL] [Abstract][Full Text] [Related]
15. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus]. D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899 [TBL] [Abstract][Full Text] [Related]
16. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294 [TBL] [Abstract][Full Text] [Related]
17. Fatal scleromyxedema: report of a case and review of the literature. Godby A; Bergstresser PR; Chaker B; Pandya AG J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):289-94. PubMed ID: 9486700 [TBL] [Abstract][Full Text] [Related]
18. Generalized papular and sclerodermoid eruption: scleromyxedema. Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020 [TBL] [Abstract][Full Text] [Related]